MS4 THE COST-EFFECTIVENESS OF ADDING INFLIXIMAB TO USUAL THERAPY IN THE TREATMENT OF PSORIATIC ARTHRITIS
May 1, 2005, 00:00
10.1016/S1098-3015(10)62585-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)62585-5/fulltext
Title :
MS4 THE COST-EFFECTIVENESS OF ADDING INFLIXIMAB TO USUAL THERAPY IN THE TREATMENT OF PSORIATIC ARTHRITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62585-5&doi=10.1016/S1098-3015(10)62585-5
First page :
Section Title :
Open access? :
No
Section Order :
24